Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIV Drug Resistance Profiles Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil

NCT04453436 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT04453436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04453436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIV Drug Resistance Profiles Among Individuals Failing Tenofovir/Lamivudine and Dolutegravir First Line Regimen in Brazil
Lead sponsor
Federal University of São Paulo
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
October 31, 2026
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug, hiv, resistance